Stay updated on Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial
Sign up to get notified when there's something new on the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page.

Latest updates to the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page no longer shows the MedlinePlus related topic links for 'Multiple Myeloma' and 'MedlinePlus Genetics', which are peripheral navigation elements rather than essential study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check26 days agoChange DetectedFooter updated to Revision: v3.3.3, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedRelated topics were added (Multiple myeloma; MedlinePlus Genetics) and the revision tag was updated from v3.3.1 to v3.3.2. These are minor metadata changes and do not alter the trial details or outcomes.SummaryDifference0.1%

- Check55 days agoChange DetectedPublications section text updated to reflect PubMed auto-filled entries, and the revision version was updated to v3.3.1; the older PubMed-related description (v3.2.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRemoved the notice about a lapse in government funding and the NIH Clinical Center’s operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check76 days agoChange DetectedThe two screenshots show no meaningful differences in core content or layout; the study details, eligibility criteria, and trial arms remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page.